Explore our latest research driving better patient outcomes
The Healthcare Outcomes and Clinical Practice Research Focus Group undertakes applied, multidisciplinary research to improve healthcare delivery, clinical practice and patient outcomes. The group brings together expertise in clinical and health services research, digital medicine, public health, medicines optimisation, pharmacy practice and healthcare education. Its work generates evidence to support safer, more effective and more equitable healthcare for patients, communities and wider society.
The group works at the interface of research, practice, policy and education, with a strong focus on translational impact. It collaborates with NHS organisations, local authorities, charities and other partners including the Wessex Academic Health Science Network and Wessex ARC and the Drug Safety Research Unit. These partnerships enable the group to address real-world healthcare priorities from the perspective of the different stakeholders in innovative and effective ways.
Areas of research:
- Digital Medicine
- Public Health
- Gastrointestinal medicine
- Medicines optimisation
- Educational research
Members of staff
Dr Helena Herrera
Dr James Brown
Dr Nick Warren
Dr Sarah Hill
Dr Helen Hull
Dr Nicola Barnes
Dr Jeremy Mills
Mr Malachi Kelly
Professor Darek Gorecki
Dr Carolina Machuca Vargas
Dr Elisavet Andrikopoulou
Related PhD projects
REVERSE
A cross-community approach to self-monitoring in pre-hypertension: a feasibility study led by Principal Investigator Dr. Paul Rutter.
DECISIONS
Looking at improving stroke care pathways.
MicroGuide-2
A health research study evaluating computerized clinical decision support tools - specifically mobile app upgrades - to optimise hospital antibiotic prescribing and combat antimicrobial resistance.
INCUBATOR
An investigation into clinical academic pathways for pharmacists.
Key publications
Godfrey Nyangadzayi Musuka, Enos Moyo, Patrick Grad Iradukunda, Gashema Pierre, Helena Herrera, Roda Madziva, Tapiwa Dhliwayo, Constantine Mutata, Noah Mataruse, Oscar Mano, Elliot Mbunge, Tafadzwa Dzinamarira
School of Medicine, Pharmacy and Biomedical Sciences, London School of Hygiene and Tropical Medicine, University of Nottingham, Durban University of Technology, ICAP at Columbia University, Columbia University, University of Pretoria
Nimra Shamim, Kelly Doughty, Hau-Tak Chau, James Brown, Robert Andrew Baldock, Ngan Pan Au
School of Medicine, Pharmacy and Biomedical Sciences
Sharon X. Lin, Thomas Phillips, David Culliford, Christopher Edwards, Christopher Holroyd, Kinda Ibrahim, Ravina Barrett, Clare Howard, Ruth Johnson, Jo Adams, Mathew Stammers, Adam Rischin, Paul Rutter, Nicola Barnes, Paul Roderick, Simon D. Fraser
Institute of Life Sciences and Healthcare, University of Southampton, University Hospital Southampton NHS Foundation Trust, University of Brighton, Health Innovation Wessex, NHS South Commissioning Support Unit
Muharib Alruwaili, Sonia Younas, Abozer Y. Elderdery, Intisar Alruwaili, Jeremy Mills, Muhammad Umer Khan, Hasan Ejaz
School of Medicine, Pharmacy and Biomedical Sciences, Institute of Life Sciences and Healthcare, Al Jouf University, Centre for Immunology and Infection (C2i)
Suraj Verma, Annalisa Occhipinti, Justyna Róg, Lukasz Bozycki, Michal Korostynski, Samuel C. Robson, Claudio Angione, Christian Pinset, Dariusz C. Gorecki*
*Corresponding author for this work
Faculty of Science & Health, Centre for Enzyme Innovation, Institute of Life Sciences and Healthcare, AFM Maj Institute of Pharmacology, PAS Teesside University, Nencki Institute of Experimental Biology of the Polish Academy of Sciences
Related research areas
Advanced Materials for Diagnosis and Therapy (AMDT) Research Group
We're researching the design, synthesis and biomedical applications of biomaterials, biosensors, drugs and drug delivery systems, and the science that underpins these technologies.
Research Group in Computational Biology
We're studying biomolecules such as DNA, RNA and proteins to allow us to tackle issues such as disease, pollution and energy.
Drug Discovery for Personalised Medicine
Discover how our interdisciplinary research is revealing the molecular mechanisms of disease and accelerating the development of targeted, personalised therapies.
